Pharming Group NV - ADRPHAR
13F holders, Q2 2024 (June 30)4holders +1
1new positions
0sold out
$8.35avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Pharming Group NV - ADR (PHAR) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Silverberg Bernstein Capital Management LLC ($196K), Morgan Stanley ($23K) and UBS Group AG ($7K).
- Company
- Pharming Group NV - ADR
- CUSIP
- 71716E105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 7,030 shares bought, net +7,030 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Silverberg Bernstein Capital Management LLC | 0.19% | Add +32.3% | 23,435 | $196K |
| Morgan Stanley | 0.00% | No change | 2,800 | $23K |
| UBS Group AG | 0.00% | Add +1417.3% | 789 | $7K |
| Osaic Holdings, Inc. | 0.00% | New | 568 | $5K |
"% of holder's portfolio" is PHAR's weight in each manager's 13F, not the share of Pharming Group NV - ADR the manager owns.